Resveratrol inhibits MRGPRX2-mediated mast cell activation via Nrf2 pathway
Copyright © 2021. Published by Elsevier B.V..
Mast cells (MCs) are crucial effectors in inflammation and allergic reactions. The Mas-related G-protein-coupled receptor X2 (MRGPRX2) was the MC-specific receptor and play a key role in IgE-independent allergic reactions. The activation of the Nuclear factor erythroid derived 2-related factor 2 (Nrf2) is involved in IgE-mediated MC degranulation. Resveratrol (Res) is a polyphenolic compound in red wine and has been reported to exert a variety of pharmacological effects. In the current study, we investigated the effect of Res in regulating MRGPRX2-mediated MC activation and its underlyingmechanism. We demonstrated that Res reduced compound 48/80 (C48/80)-induced calcium flux in MCs and inhibited MCs degranulation in vitro. Res also suppressed C48/80-induced hind paw extravasation, active systemic anaphylaxis, and MCs degranulation in mouse models of pseudo-allergy in vivo. Furthermore, PCR and immunohistochemistry assay suggest that Res up-regulates Nrf2 expression and Nrf2 inhibitor attenuates the protective effects of Res. In conclusion, Res exerts an inhibitory effect on MRGPRX2-mediated MCs activation by targeting Nrf2 pathway and may present a promising new therapeutic agent for the treatment of MRGPRX2-dependent anaphylactoid reactions.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:93 |
---|---|
Enthalten in: |
International immunopharmacology - 93(2021) vom: 01. Apr., Seite 107426 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Wang, Jue [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anti-Allergic Agents |
---|
Anmerkungen: |
Date Completed 28.05.2021 Date Revised 28.05.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.intimp.2021.107426 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM321105648 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM321105648 | ||
003 | DE-627 | ||
005 | 20231225175115.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.intimp.2021.107426 |2 doi | |
028 | 5 | 2 | |a pubmed24n1070.xml |
035 | |a (DE-627)NLM321105648 | ||
035 | |a (NLM)33550032 | ||
035 | |a (PII)S1567-5769(21)00062-X | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Wang, Jue |e verfasserin |4 aut | |
245 | 1 | 0 | |a Resveratrol inhibits MRGPRX2-mediated mast cell activation via Nrf2 pathway |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.05.2021 | ||
500 | |a Date Revised 28.05.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2021. Published by Elsevier B.V. | ||
520 | |a Mast cells (MCs) are crucial effectors in inflammation and allergic reactions. The Mas-related G-protein-coupled receptor X2 (MRGPRX2) was the MC-specific receptor and play a key role in IgE-independent allergic reactions. The activation of the Nuclear factor erythroid derived 2-related factor 2 (Nrf2) is involved in IgE-mediated MC degranulation. Resveratrol (Res) is a polyphenolic compound in red wine and has been reported to exert a variety of pharmacological effects. In the current study, we investigated the effect of Res in regulating MRGPRX2-mediated MC activation and its underlyingmechanism. We demonstrated that Res reduced compound 48/80 (C48/80)-induced calcium flux in MCs and inhibited MCs degranulation in vitro. Res also suppressed C48/80-induced hind paw extravasation, active systemic anaphylaxis, and MCs degranulation in mouse models of pseudo-allergy in vivo. Furthermore, PCR and immunohistochemistry assay suggest that Res up-regulates Nrf2 expression and Nrf2 inhibitor attenuates the protective effects of Res. In conclusion, Res exerts an inhibitory effect on MRGPRX2-mediated MCs activation by targeting Nrf2 pathway and may present a promising new therapeutic agent for the treatment of MRGPRX2-dependent anaphylactoid reactions | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a MRGPRX2 | |
650 | 4 | |a Mast cell | |
650 | 4 | |a Nrf2 | |
650 | 4 | |a Resveratrol | |
650 | 7 | |a Anti-Allergic Agents |2 NLM | |
650 | 7 | |a Mrgprx2 protein, mouse |2 NLM | |
650 | 7 | |a NF-E2-Related Factor 2 |2 NLM | |
650 | 7 | |a Nfe2l2 protein, mouse |2 NLM | |
650 | 7 | |a Receptors, G-Protein-Coupled |2 NLM | |
650 | 7 | |a Resveratrol |2 NLM | |
650 | 7 | |a Q369O8926L |2 NLM | |
700 | 1 | |a Zhang, Yongjing |e verfasserin |4 aut | |
700 | 1 | |a Hu, Shiling |e verfasserin |4 aut | |
700 | 1 | |a Ge, Shuai |e verfasserin |4 aut | |
700 | 1 | |a Jia, Min |e verfasserin |4 aut | |
700 | 1 | |a Wang, Nan |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International immunopharmacology |d 2001 |g 93(2021) vom: 01. Apr., Seite 107426 |w (DE-627)NLM112639542 |x 1878-1705 |7 nnns |
773 | 1 | 8 | |g volume:93 |g year:2021 |g day:01 |g month:04 |g pages:107426 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.intimp.2021.107426 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 93 |j 2021 |b 01 |c 04 |h 107426 |